Special Issue "Diagnosis, Treatment, and Prevention of Viral Hemorrhagic Fever Diseases"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against (re)emerging and Tropical Infections Diseases".
Deadline for manuscript submissions: 31 March 2023 | Viewed by 82
Interests: emerging/re-emerging viruses; zoonotic viral infections; viral hepatitis and gastroenteritis; molecular epidemiology; diagnostics; mutagenesis; public health
Interests: bat and rodent virus discovery; virus isolation; virus–host interaction; viral pathogenesis; viral ecology; emerging infectious diseases; attenuated and inactivated vaccines
Special Issues, Collections and Topics in MDPI journals
Viral hemorrhagic fever (VHF) disease is characterized by a syndrome of acute febrile illness, increased vascular permeability, and coagulation defects. Hemorrhagic fever viruses frequently belong to the taxonomic families, Arenaviridae, Hantaviridae, Filoviridae, Flaviviridae, Nairoviridae, which are primarily harbored by rodents or arthropods and transmitted to humans through direct or indirect contact. Considering the great morbidity and mortality of some VHFs, infections of their causative agents can become critical clinical burdens, particularly in medical-resource-limited regions. Notably, highly pathogenic VHF viruses are still circulating and causing devastating outbreaks around the globe, leading to significant public health concerns. However, the molecular pathogenesis and pathophysiology of VHF are largely unknown since validated animal models for VHF studies are lacking. Furthermore, the availability of protective vaccines and effective treatments against VHF is currently very limited.
This Special Issue of Vaccines focuses on the difficult challenges and recent advances that have been made in the field of VHF research, which aims to promote studies on the prevention and control of VHF. Specifically, this Special Issue will contain original research articles, reviews, and short communications on various topics of VHF, including, but not limited to: epidemiology, transmission, pathogenesis, diagnostic techniques, animal models, vaccine development, and therapeutic intervention
Dr. Bo Wang
Prof. Dr. Xinglou Yang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- viral hemorrhagic fever diseases
- diagnostic tools
- animal models
- vaccine development
- therapeutic intervention